期刊文献+

肺癌患者血清胱抑素C检测的临床意义 被引量:4

下载PDF
导出
摘要 目的探讨肺癌患者血清胱抑素C含量检测的临床意义。方法健康查体人员40例为健康对照组,肺癌患者93例为肺癌组,用酶联免疫吸附试验检测2组血清胱抑素C含量,比较2组间及肺癌组中化疗与未化疗、转移与未转移患者血清胱抑素C含量的情况。结果肺癌组与健康对照组胱抑素C含量[分别为(6.08±2.76)mg/L与(0.73±0.11)mg/L]比较,差异有统计学意义(t=13.66,P〈0.01),化疗与未化疗、转移与未转移患者比较差异无统计学意义(t=0.9257,t=0.3550,均P〉0.05)。结论肺癌患者血清胱抑素C检测值远远高于正常人群,提示血清胱抑素C检测在肺癌的早期诊断、治疗等方面可能会有很重要的临床意义。
出处 《中国医药》 2009年第8期586-587,共2页 China Medicine
  • 相关文献

同被引文献60

  • 1刘运双,曾平,彭国瑞,罗军,张亚梅.颗粒增强透射免疫分析法测定血清胱抑素C方法学评价[J].国际检验医学杂志,2006,27(7):609-611. 被引量:9
  • 2Perrone RD, Madias NE, Levy AS. Serum creatinine as an index of renal function : new insights into old concepts [ J ]. Clin Chem, 1992,38(10) :1933-1953.
  • 3Ahn MJ, Park CK, Choi JH, et al. Clinical significance of mi- crovessel density in multiple myeloma patients [ J ]. Korean Med Sci, 2001,16 ( 1 ) :45-50. DOI : 10. 3346/jkms. 2001.16.1. 45.
  • 4Merlini G, Baldini L, Broglia C, et al. Prognostic factors in symp- tomatic Waldenstrom' s macroglobulinemia [ J ]. Semin oncol, 2003,30(2) :211-215. DOI: 10. 1053/sonc. 2003. 50064.
  • 5Finney H, Newman D J, Price CP. Adult reference ranges for ser- um cystatin C, creatinine and predicted creatinine clearance[ J]. Ann Clin Biochem, 2000, 37 ( Pt 1 ) : 49-59. DOI: 10. 1258/ 0004563001901524.
  • 6Laterza OF, Price CP, Scott MG. Cystatin C: an improved estima- tor of glomerular filtration rate ? [ J]. Clin Chem, 2002,48 (5) :699-707.
  • 7Turk V, Stoka V, Vasiljeva O, et al. Cysteine cathepsins: from structure, function and regulation to new frontiers [ J ]. Biochim Biophys Acta, 2012,1824(1 ) :68-85. DOI: 10. 1016@ bbapap. 2011.10. 002.
  • 8Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms [ J ]. J Clin Invest, 1999,104(9) :1191-1197. DO1: 10. 1172/JCI7709.
  • 9Eriksson P, Deguchi H, Samnegtrd A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease[J]. Arterioscler Thromb Vasec Biol,2004, 24(3) :511-517. DOI: 10. 1161/01. ATV. 0000117180. 57731. 36.
  • 10Lassus J, Harjola VP. Cystatin C: a step forward in assessing kidney function and cardiovascular risk [ J ]. Heart Fail Rev, 2012,17(2) :251-261. DOI: 10. 1007/s10741-011-9242-6.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部